Inactive Instrument

All News Provention Bio, Inc.

Equities

PRVB

US74374N1028

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Pharmaceuticals Select Industry Index	23-05-02	CI
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Global BMI Index	23-05-02	CI
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P TMI Index	23-05-02	CI
Improving Confidence in Eurozone Economy Lifts French Shares Amid Q1 Results Outpour	23-04-27	MT
Sanofi Completes Provention Bio Acquisition	23-04-27	MT
Sanofi: acquisition of Provention Bio finalized	23-04-27	CF
Provention Bio : Termination of Material Agreement - Form 8-K	23-04-27	PU
PROVENTION BIO, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
Provention Bio, Inc. Appoints Debora Pellicano as Chief Financial Officer	23-04-27	CI
Provention Bio, Inc. Announces Management Changes	23-04-27	CI
Sanofi Closes $3 Billion Acquisition of Provention Bio	23-04-27	MT
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Composite Index	23-04-27	CI
Sanofi completed the acquisition of 97.1% stake in Provention Bio, Inc..	23-04-26	CI
Sanofi: waiting period expires for Provention Bio	23-04-26	CF
Sanofi Secures US Antitrust Clearance for $2.9 Billion Provention Bio Takeover	23-04-26	MT
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Biotechnology Index	23-04-26	CI
Sanofi wins US drug control from AstraZeneca in Sobi deal	23-04-11	AN
Sanofi Extends Offer Period for Provention Bio Takeover Amid US Regulatory Review	23-04-11	MT
Sanofi Announces $2.9 Billion Acquisition Of BioPharma Diabetes Drug Maker	23-04-10	AQ
PROVENTION BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Provention Bio, Inc.

Equities

PRVB

US74374N1028

All News

Filters